Argatroban for anticoagulation during cardiac surgery
Authors:
- 13 December 2006
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 78 (2) , 161-166
Abstract
Background: The aim of this study was to report our experience and review the published data on argatroban administration during adult cardiac surgery. Methods: The information on all reported cases of argatroban use in adults, during cardiac surgery was reviewed, including that of the patient described here. This analysis focused on patient characteristics, type of surgery, argatroban dosing schedule, monitoring of anticoagulation and outcomes. Results: Twenty‐one cases have been reported. Fifteen patients underwent off‐pump surgical procedures with the argatroban dose adjusted to maintain an activated clotting time (ACT) range between 200 and 300 s. Three intraoperative thrombi occurred in two patients when the ACT was 400 s. Intraoperative thrombotic complications were not reported in this group; however, one clot in the pump was noted after the procedure when the ACT was between 300 and 350 s. All six cases required larger volumes of perioperative blood products and three had severe coagulopathy. Of the 21 cases, seven had an indication for continued anticoagulation following surgery. Four cases did not report further use of argatroban after surgery. Three patients received argatroban after surgery without complications. Recommendations for how to use argatroban during cardiac surgery are proposed. Conclusions: Argatroban, with ACT monitoring, might be safely used for anticoagulation during cardiac surgery.Keywords
This publication has 20 references indexed in Scilit:
- A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON studyThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: The results of the EVOLUTION-OFF studyThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Etiology of thrombocytopenia in all patients treated with heparin productsEuropean Journal of Haematology, 2005
- Severe Argatroban-Induced Coagulopathy in a Patient With a History of Heparin-Induced ThrombocytopeniaThe Annals of Thoracic Surgery, 2004
- Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingThe American Journal of Cardiology, 2004
- Failure of argatroban anticoagulation during off-pump coronary artery bypass surgeryThe Annals of Thoracic Surgery, 2004
- How I treat heparin-induced thrombocytopenia and thrombosisBlood, 2003
- Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patientsJournal of Cardiothoracic and Vascular Anesthesia, 2000
- Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight HeparinCirculation, 1999
- Heparin and Low-Molecular-Weight HeparinChest, 1998